Skip to Content

Veramyst Approval History

FDA Approved: Yes (Discontinued) (First approved April 27, 2007)
Brand name: Veramyst
Generic name: fluticasone furoate
Dosage form: Nasal Spray
Company: GlaxoSmithKline
Treatment for: Allergic Rhinitis

Marketing Status: Discontinued

Veramyst (fluticasone furoate) is an intranasal corticosteroid administered once-daily for the treatment of seasonal and year- round allergy symptoms in adults and children two years of age and older.

On August 2, 2016, the FDA announced the approval of Flonase Sensimist Allergy Relief (fluticasone furoate, 27.5 mcg spray) as an over-the-counter (OTC) replacement for the prescription product Veramyst.

Development History and FDA Approval Process for Veramyst

DateArticle
Apr 29, 2007Approval FDA Approves Once-Daily Veramyst (fluticasone furoate) Nasal Sprayfor Treatment of Seasonal and Year-Round Allergy Symptoms in Adultsand Children as Young as Two Years
Jul 27, 2006New Seasonal and Perennial Rhinitis Intranasal Treatment Submitted for U.S. and European Marketing Approval

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide